title: Antifibrinolytic Therapy for Cardiac Surgery: An Update.
authors.affiliation: From the Institute for Anesthesiology, Heart and Diabetes Centre North-Rheine Westphalia, Bad Oeynhausen, Ruhr-University Bochum, Bochum, Germany (A.K.); Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts (D.F.); and Department of Anesthesiology and Intensive Care, Duke University School for Medicine, Durham, North Carolina (J.H.L.).
authors.forename: Andreas
authors.initials: A
authors.lastname: Koster
authors.forename: David
authors.initials: D
authors.lastname: Faraoni
authors.forename: Jerrold H
authors.initials: JH
authors.lastname: Levy
mesh_terms: D000933:Antifibrinolytic Agents / Q000008:administration & dosage*; D007611:Aprotinin / Q000008:administration & dosage; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000639:trends; D002986:Clinical Trials as Topic / Q000639:trends; D006801:Humans
chemical_list: D000933:Antifibrinolytic Agents; D007611:Aprotinin